# Green Revolution: The Rise of Cannabis in Modern Society &#8211; Vow FM

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/cannabis-compounds-affect-endocannabinoid-system/
> **Published:** 2026-03-24T19:17:25-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:40:06-04:00
> **Clinical Summary:** Explore how cannabis compounds affect the endocannabinoid system and their clinical relevance in modern society's evolving cannabis medicine landscape.

---

✦ New

 CED Clinical Relevance
 #35
 Clinical Context
 Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape.

ResearchPolicyNeurologyMental Health

 Why This Matters
 Clinicians need to understand how [cannabis compounds](https://cedclinic.com/cannabis-terpene-synergy-entourage-effect/) affect the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) to properly counsel patients on potential cognitive and emotional effects, particularly for vulnerable populations like adolescents with developing brains. As cannabis use becomes more socially normalized, clinicians must be equipped to screen for problematic use patterns, assess drug interactions with prescribed medications, and provide evidence-based guidance on risks versus potential [therapeutic benefits](https://cedclinic.com/therapeutic-benefits-of-thc/) for specific conditions.

 Clinical Summary
 

Cannabis compounds interact with the endocannabinoid system to modulate cognitive and emotional processes, a mechanism increasingly relevant to clinical practice as legalization expands access and clinical evidence accumulates. Clinicians should understand that cannabinoids affect central nervous system regulation through well-characterized receptor pathways, which explains both therapeutic potential and adverse effects observed in patient populations. As cannabis use becomes more socially accepted and legally available, practitioners need evidence-based knowledge about endocannabinoid physiology to counsel patients on appropriate use, drug interactions, and contraindications. The rising prevalence of cannabis use in modern society means clinicians across specialties will encounter patients using these compounds for symptom management, necessitating competent clinical assessment and integration into care plans. Clinicians should familiarize themselves with the basic neurobiology of cannabinoids and current evidence to provide informed guidance rather than dismissing or uncritically endorsing patient use.

 Dr. Caplan’s Take
 “What we’re seeing now is patients finally gaining access to a system of medicine that directly modulates their own endocannabinoid signaling, and after two decades of clinical practice, I can tell you the therapeutic potential is real, but it requires the same rigorous dosing protocols and drug interaction screening we apply to any other medication.”

 Clinical Perspective
 
 

While cannabis use continues to expand in legalized jurisdictions, clinicians should recognize that public messaging often emphasizes the endocannabinoid system’s role in regulating cognition and emotion without adequate discussion of dose-response relationships, individual genetic variation in [cannabinoid metabolism](https://cedclinic.com/fatty-acid-amide-hydrolase-obesity-risk-genetic-links/), or the substantial heterogeneity in product potency and composition across markets. The evidence base for specific clinical applications remains limited and inconsistent, particularly regarding long-term neuropsychiatric outcomes in vulnerable populations such as adolescents and those with personal or family histories of psychotic disorders. When patients disclose cannabis use, providers should conduct a structured assessment that includes frequency, product type (flower versus concentrate), THC/CBD ratios, and any concurrent medications or psychiatric symptoms, as these factors substantially influence both therapeutic potential and risk. A practical approach involves screening for problematic use patterns, documenting use in the medical record, and providing evidence-based counseling that acknowledges

 

 

💬 Join the Conversation

 

Have a question about how this applies to your situation?
 [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

 

Want to discuss this topic with other patients and caregivers?
 [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/)

Have thoughts on this? Share it:

[𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+GREEN+REVOLUTION%3A+THE+RISE+OF+CANNABIS+IN+MODERN+SOCIETY+-+Vow+FM+%40drcaplan&url=https%3A%2F%2Fvowfm.co.za%2F2026%2F03%2F24%2Fgreen-revolution-the-rise-of-cannabis-in-modern-society%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fvowfm.co.za%2F2026%2F03%2F24%2Fgreen-revolution-the-rise-of-cannabis-in-modern-society%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+GREEN+REVOLUTION%3A+THE+RISE+OF+CANNABIS+IN+MODERN+SOCIETY+-+Vow+FM+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fvowfm.co.za%2F2026%2F03%2F24%2Fgreen-revolution-the-rise-of-cannabis-in-modern-society%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/)

 Related Articles
 
- GREEN REVOLUTION: THE RISE OF CANNABIS IN MODERN SOCIETY – Vow FM

📰 Source: [https://vowfm.co.za/2026/03/24/green-revolution-the-rise-of-cannabis-in-modern-society/](https://vowfm.co.za/2026/03/24/green-revolution-the-rise-of-cannabis-in-modern-society/)

 Further Reading
 CED Clinic BlogTaxpayers to fund clear-up of huge illegal waste dumps
 Research DigestCED Regulatory Digest, Since Last Digest, 1 items
 Evidence Watch[Cannabinoid Oral Mucosal Delivery: Approaches to Formulation, Fabrication, and Permeation Enhancement.](https://cedclinic.com/oral-cannabinoid-bioavailability-delivery-absorption/)

 
 
 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

 
 Physician-Led, Whole-Person Care
 A doctor who takes the time to truly understand you.
 Personal care that starts with listening and is guided by experience and ingenuity.

 
 Health, Longevity, Wellness
 One-on-One Cannabis Guidance
 Metabolic Balance
 

 
 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 
 

 
 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[Exploring Cannabinoids and Their Role in Patient Care – Cannabis News | NUG Magazine](https://cedclinic.com/cannabinoid-therapeutics-clinical-practice-patient-care/)

An in-depth look at cannabinoids and their therapeutic roles in patient care, providing valuable insights for clinicians.

[Read More](https://cedclinic.com/cannabinoid-therapeutics-clinical-practice-patient-care/)

[What Managed Care Needs to Know About Cannabinoids and Sleep: Mark Malesker, PharmD](https://cedclinic.com/what-managed-care-needs-to-know-about-cannabinoids-and-sleep-mark-malesker-pharmd/)

A detailed discussion on cannabinoids' effects on sleep and implications for managed care providers.

[Learn More](https://cedclinic.com/what-managed-care-needs-to-know-about-cannabinoids-and-sleep-mark-malesker-pharmd/)

[United States Cannabis Market Set for Explosive Growth Amid Legalization and Innovation](https://cedclinic.com/united-states-cannabis-market-growth-legalization-innovation/)

Insights into the expanding cannabis market in the U.S. driven by legalization and innovative developments.

[Explore Now](https://cedclinic.com/united-states-cannabis-market-growth-legalization-innovation/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
